CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −18 | $796.43 | $14K | 32,133 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −28 | $797.43 | $22K | 32,105 |
| 2023-02-03 | Fenimore Christopher R. SVP Controller | Option exercise | +5,000 | $270.43 | $1.4M | 23,581 |
| 2023-02-03 | Fenimore Christopher R. SVP Controller | Shares withheld for taxes | −3,286 | $774.29 | $2.5M | 20,295 |
| 2023-02-03 | Fenimore Christopher R. SVP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −5,000 | 0 | ||
| 2023-02-03 | Bassler Bonnie L Director | Option exercise | +1,021 | $380.95 | $389K | 2,268 |
| 2023-02-03 | Bassler Bonnie L Director | Sale | −1,021 | $779.00 | $795K | 1,247 |
| 2023-02-03 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −1,021 | 3,720 | ||
| 2023-02-03 | Landry Robert E EVP Finance CFO | Sale | −739 | $764.50 | $565K | 32,105 |
| 2023-02-03 | Landry Robert E EVP Finance CFO | Option exercise | +3,000 | $381.92 | $1.1M | 35,105 |
| 2023-02-03 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −2,248 | $774.29 | $1.7M | 32,857 |
| 2023-02-03 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −3,000 | 800 | ||
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −2 | $752.11 | $2K | 19,345 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −18 | $753.54 | $14K | 19,327 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −17 | $754.45 | $13K | 19,310 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −17 | $755.50 | $13K | 19,293 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −24 | $756.77 | $18K | 19,269 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −2 | $757.29 | $2K | 19,267 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −7 | $758.58 | $5K | 19,260 |
| 2023-02-01 | RYAN ARTHUR F Director | Sale | −4 | $759.65 | $3K | 19,256 |
Page 58 of 105 · 2,088 trades